MA
Mohammadhussain Abdulgani Rayma
About Mohammadhussain Abdulgani Rayma
Data last updated:
Mohammadhussain Abdulgani Rayma is a Designated Partner at Med Xpress Pharma India Llp (since 2025). The company operates in E-Commerce. Med Xpress Pharma India Llp reported revenue of ₹12.47 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Med Xpress Pharma India Llp AAF-8773 | Designated Partner | 01 Apr 2025 | 2016 | ₹12.47 Cr (FY 2023) | Active |
Board colleagues of Mohammadhussain Abdulgani Rayma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nitin Kakasaheb Suryavanshi | 11121495 | Med Xpress Pharma India Llp | Designated Partner |
| Prafull Babu Kalyanshetti | 07402828 | Med Xpress Pharma India Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammadhussain Abdulgani Rayma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammadhussain Abdulgani Rayma
Mohammadhussain Abdulgani Rayma currently holds 1 directorship: Med Xpress Pharma India Llp (Designated Partner, since 01 Apr 2025, revenue ₹12.47 Cr (FY 2023)).
Mohammadhussain Abdulgani Rayma was first appointed on 01 Apr 2025 as Designated Partner at Med Xpress Pharma India Llp.
The current boards of Mohammadhussain Abdulgani Rayma's companies include Nitin Kakasaheb Suryavanshi (Med Xpress Pharma India Llp), Prafull Babu Kalyanshetti (Med Xpress Pharma India Llp).